SCHEMBL31708141

SCHEMBL31708141

CNC(=O)C(=O)c1c[nH]c2cc(C)cc(OC(C)=O)c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR4A2 P43354 2/20 0.37
▸ SLC22A6 Q4U2R8 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ CASP3 P42574 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SENP7 Q9BQF6 1/20 0.34
▸ ELANE P08246 1/20 0.33
▸ IGF1R P08069 2/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ MET P08581 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ GABRP O00591 1/20 0.32
▸ GABRD O14764 1/20 0.32
▸ GABRA1 P14867 1/20 0.32
▸ GABRB1 P18505 1/20 0.32
▸ GABRG2 P18507 1/20 0.32
▸ GABRB3 P28472 1/20 0.32
▸ GABRA5 P31644 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31708171 0.84 SLC22A6 (0.38) NR4A2SLC22A6KDM4EHSD17B10RAB9A
SCHEMBL31708134 0.81 SLC22A6 (0.47) NR4A2SLC22A6KDM4EHSD17B10NPC1
SCHEMBL31708047 0.73 GABRP (0.37) SLC22A6KDM4EGABRPGABRDGABRA1
SCHEMBL25424327 0.70 NR4A2 (0.40) NR4A2RAB9AKCNH2ALDH1A1GABRP
SCHEMBL31708153 0.70 SLC22A6 (0.38) SLC22A6KDM4EHSD17B10ALDH1A1
SCHEMBL25438139 0.68 NR4A2 (0.39) NR4A2KDM4ENPC1KCNH2ALDH1A1
SCHEMBL17417628 0.68 NR4A2 (0.43) NR4A2KDM4EALDH1A1
SCHEMBL31708191 0.68 HTR1A (0.44) IGF1RGABRPGABRDGABRA1GABRB1
SCHEMBL31708138 0.68 SLC22A6 (0.44) NR4A2SLC22A6
SCHEMBL30276861 0.68 ALOX5 (0.44) NR4A2SLC22A6IGF1RGABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4635492-A2 TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS Gilgamesh Pharmaceuticals, Inc. (US) 2025-10-22 — — EP disclosed
Send feedback